Primary disseminated multifocal Ewing sarcoma: Results of the Euro-EWING 99 trial

Journal of Clinical Oncology

Volumn 28, Issue 20, 2010, Pages 3284-3291

  Ladenstein, Ruth ^a   Pötschger, Ulrike ^a   Le Deley, Marie Cécile ^a   Whelan, Jeremy ^a   Paulussen, Michael ^a   Oberlin, Odile ^a   Van Den Berg, Henk ^a   Dirksen, Uta ^a   Hjorth, Lars ^a   Michon, Jean ^a   Lewis, Ian ^a   Craft, Alan ^a   Jürgens, Heribert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; VINCRISTINE; ANTINEOPLASTIC AGENT; IVA PROTOCOL;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW METASTASIS; BONE METASTASIS; CANCER PATIENT; CHILD; EVENT FREE SURVIVAL; EWING SARCOMA; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TUMOR VOLUME; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; INFANT; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HUMANS; IFOSFAMIDE; INFANT; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SARCOMA, EWING'S; VINCRISTINE;

EID: 77954727583     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.9864     Document Type: Article

References (45)

1. Stewart DA, Gyonyor E, Paterson AH, et al: High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor. Bone Marrow Transplant 18:315-318, 1996 (Pubitemid 26283680)
2. Craft A, Cotterill S, Malcolm A, et al: Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol 16:3628-3633, 1998 (Pubitemid 28506777)
3. Cotterill SJ, Ahrens S, Paulussen M, et al: Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18:3108-3114, 2000
4. Barker LM, Pendergrass TW, Sanders JE, et al: Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol 23:4354-4362, 2005 (Pubitemid 46207009)
5. Craft AW, Cotterill SJ, Bullimore JA, et al: Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1): United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33:1061-1069, 1997
6. Fizazi K, Dohollou N, Blay JY, et al: Ewing's family of tumors in adults: Multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 16:3736-3743, 1998 (Pubitemid 29001524)
7. Oberlin O, Deley MC, Bui BN, et al: Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: The third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 85:1646-1654, 2001 (Pubitemid 34081507)
8. Sluga M, Windhager R, Lang S, et al: A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Eur J Surg Oncol 27:569-573, 2001 (Pubitemid 32842729)
9. Jenkin RD, Al-Fawaz I, Al-Shabanah MO, et al: Metastatic Ewing sarcoma/PNET of bone at diagnosis: Prognostic factors - a report from Saudi Arabia. Med Pediatr Oncol 37:383-389, 2001 (Pubitemid 32959650)
10. Meyers PA, Krailo MD, Ladanyi M, et al: High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 19:2812-2820, 2001 (Pubitemid 32538189)
11. Williams BA, Williams KM, Doyle J, et al: Metastatic rhabdomyosarcoma: A retrospective review of patients treated at the hospital for sick children between 1989 and 1999. J Pediatr Hematol Oncol 26:243-247, 2004
12. Blay JY, Bouhour D, Ray-Coquard I, et al: High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol 18:3643-3650, 2000
13. Paulussen M, Ahrens S, Burdach S, et al: Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies - European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9:275-281, 1998 (Pubitemid 28186797)
14. Cangir A, Vietti TJ, Gehan EA, et al: Ewing's sarcoma metastatic at diagnosis: Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66:887-893, 1990 (Pubitemid 20307920)
15. Donaldson SS, Torrey M, Link MP, et al: A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346 - Pediatric Oncology Group. Int J Radiat Oncol Biol Phys 42:125-135, 1998 (Pubitemid 28435605)
16. Grier HE: The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 44:991-1004, 1997
17. Jürgens H, Exner U, Gadner H, et al: Multidisciplinary treatment of primary Ewing's sarcoma of bone: A 6-year experience of a European Cooperative Trial. Cancer 61:23-32, 1988 (Pubitemid 18023106)
18. Kushner BH, Meyers PA, Gerald WL, et al: Very-high-dose short-term chemotherapy for poorrisk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 13:2796-2804, 1995
19. Pinkerton CR, Bataillard A, Guillo S, et al: Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 37:1338-1344, 2001 (Pubitemid 32588743)
20. Paulussen M, Ahrens S, Craft AW, et al: Ewing's tumors with primary lung metastases: Survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 16:3044-3052, 1998 (Pubitemid 28417425)
21. Oberlin O, Rey A, Desfachelles AS, et al: Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: A study by the Societe Francaise des Cancers de l'Enfant. J Clin Oncol 24:3997-4002, 2006 (Pubitemid 46630750)
22. Grier HE, Krailo MD, Tarbell NJ, et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694-701, 2003 (Pubitemid 36237038)
23. Juergens C, Weston C, Lewis I, et al: Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 47:22-29, 2006 (Pubitemid 43787904)
24. Evans RG, Nesbit ME, Gehan EA, et al: Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: A report from the second intergroup study. J Clin Oncol 9:1173-1180, 1991
25. Rosito P, Mancini AF, Rondelli R, et al: Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: A preliminary report of 6 years of experience. Cancer 86:421-428, 1999 (Pubitemid 29347404)
26. Marina NM, Pappo AS, Parham DM, et al: Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: A feasibility study at St Jude Children's Research Hospital. J Clin Oncol 17:180-190, 1999 (Pubitemid 29022392)
27. Burdach S, van Kaick B, Laws HJ, et al: Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors: An update after longterm follow-up from two centers of the European Intergroup study EICESS - Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St Anna Kinderspital, Vienna, Austria. Ann Oncol 11:1451-1462, 2000
28. Kushner BH, Meyers PA: How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 19:870-880, 2001 (Pubitemid 32119103)
29. Marina N, Meyers PA: High-dose therapy and stem-cell rescue for Ewing's family of tumors in second remission. J Clin Oncol 23:4262-4264, 2005 (Pubitemid 46207000)
30. Atra A, Whelan JS, Calvagna V, et al: Highdose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant 20:843-846, 1997 (Pubitemid 27493921)
31. Diaz MA, Vicent MG, Madero L: High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant 24:1157-1159, 1999 (Pubitemid 30021206)
32. Hawkins D, Barnett T, Bensinger W, et al: Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors. Med Pediatr Oncol 34:328-337, 2000 (Pubitemid 30230607)
33. Ladenstein R, Lasset C, Pinkerton R, et al: Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: A report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 15:697-705, 1995
34. Burdach S, Jurgens H, Peters C, et al: Myeloablative radiochemotherapy and hematopoietic stemcell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 11:1482-1488, 1993 (Pubitemid 23228252)
35. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977 (Pubitemid 8018922)
36. Machin D, Cheung YB, Parmar M: Survival Analysis: A Practical Approach. Chichester, United Kingdom, John Wiley & Sons, 2006
37. Harrell FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2001
38. Sullivan LM, Massaro JM, D'Agostino RB Sr: Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 23:1631-1660, 2004 (Pubitemid 38660414)
39. Klein JP, Rizzo JD, Zhang MJ, et al: Statistical methods for the analysis and presentation of the results of bone marrow transplants: Part 2. Regression modeling. Bone Marrow Transplant 28:1001-1011, 2001 (Pubitemid 34030645)
40. Kasper B, Lehnert T, Bernd L, et al: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant 34:37-41, 2004 (Pubitemid 39022955)
41. Horowitz ME, Kinsella TJ, Wexler LH, et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918, 1993
42. Kolb EA, Kushner BH, Gorlick R, et al: Longterm event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 21:3423-3430, 2003 (Pubitemid 46594075)
43. Felgenhauer J, Hawkins D, Pendergrass T, et al: Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas. Med Pediatr Oncol 34:29-38, 2000 (Pubitemid 30022706)
44. Haeusler J, Ranft A, Boelling T, et al: The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 116:443-450, 2010
45. Kolb EA, Gorlich R: Development of IGF-IR inhibitors in pediatric sarcomas. Curr Oncol Rep 11:307-313, 2009